Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (161-170 of 400) with videos related to

Pageof 40
Sort By:
Stroke|October 23, 2010
Hepatitis C virus infection and increased risk of cerebrovascular diseaseMei-Hsuan Lee, Hwai-I Yang, Chih-Hao Wang, et al.
The American Journal of Gastroenterology|March 6, 2009
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infectionChing-Sheng Hsu, Chen-Hua Liu, Chun-Jen Liu, et al.
Hepatology International|April 22, 2021
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patientsHuei-Ru Cheng, Hung-Chih Yang, Su-Ru Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2013
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis CTung-Hung Su, Chen-Hua Liu, Chun-Jen Liu, et al.
The Journal of Infectious Diseases|October 2, 2019
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisTung-Hung Su, Cheng-Yuan Peng, Tai-Chung Tseng, et al.
Journal of Medical Virology|May 20, 2024
Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotypingYu-Ping Chang, Chiuan-Bo Huang, Tung-Hung Su, et al.
Scientific Reports|January 19, 2026
Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cureYu-Ping Chang, Yun-Chu Chen, Tung-Hung Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapyWang-Huei Sheng, Chien-Ching Hung, Sui-Yuan Chang, et al.
World Journal of Gastrointestinal Oncology|February 4, 2022
Effects of <i>Helicobacter pylori</i> infection in gastrointestinal tract malignant diseases: From the oral cavity to rectumYang-Che Kuo, Lo-Yip Yu, Horng-Yuan Wang, et al.
Journal of Gastroenterology and Hepatology|August 2, 2017
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Pageof 40

Showing results (161-170 of 400) with videos related to

Sort By:
Pageof 40
Stroke|October 23, 2010
Hepatitis C virus infection and increased risk of cerebrovascular diseaseMei-Hsuan Lee, Hwai-I Yang, Chih-Hao Wang, et al.
The American Journal of Gastroenterology|March 6, 2009
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infectionChing-Sheng Hsu, Chen-Hua Liu, Chun-Jen Liu, et al.
Hepatology International|April 22, 2021
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patientsHuei-Ru Cheng, Hung-Chih Yang, Su-Ru Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2013
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis CTung-Hung Su, Chen-Hua Liu, Chun-Jen Liu, et al.
The Journal of Infectious Diseases|October 2, 2019
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisTung-Hung Su, Cheng-Yuan Peng, Tai-Chung Tseng, et al.
Journal of Medical Virology|May 20, 2024
Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotypingYu-Ping Chang, Chiuan-Bo Huang, Tung-Hung Su, et al.
Scientific Reports|January 19, 2026
Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cureYu-Ping Chang, Yun-Chu Chen, Tung-Hung Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapyWang-Huei Sheng, Chien-Ching Hung, Sui-Yuan Chang, et al.
World Journal of Gastrointestinal Oncology|February 4, 2022
Effects of <i>Helicobacter pylori</i> infection in gastrointestinal tract malignant diseases: From the oral cavity to rectumYang-Che Kuo, Lo-Yip Yu, Horng-Yuan Wang, et al.
Journal of Gastroenterology and Hepatology|August 2, 2017
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Pageof 40